A europium (III)-sensitized, spectrofluorimetric (FL) method is presented for the determination of sparfloxacin (SPAR) using an anionic surfactant, sodium dodecyl benzene sulphonate (SDBS). The method is based on the strong fluorescence (FL) enhancement of SPAR after the addition of Eu 3+ ions as fluorescence probes. The experimental results indicated that the FL intensity of the SPAR-Eu 3+ system was enhanced markedly by SDBS. The maximum FL emission signal was obtained at about 615 nm when excited at 372 nm. The experimental conditions that affected the FL intensity of the SPAR-Eu
Introduction
Sparfloxacin (SPAR), [5-amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid], is a broad spectrum, third generation fluoroquinolone antibiotic. It is active against both Grampositive and Gram-negative bacteria and has moderate activity against anaerobes and Mycobacteria.
1 It is used in the treatment of various bacterial infections, including urinary tract infections, lung infections such as bronchitis or pneumonia, sinus infections and some other types of infection, because of its excellent activity against various bacteria and good absorption on oral administration.
2 Therefore, it is necessary to develop a simple and sensitive analytical method for the determination of SPAR due to its clinical, pharmaceutical and biological advantages.
Several analytical methods have been reported for determining SPAR including high performance liquid chromatography, [3] [4] [5] [6] liquid chromatography, 7 high-performance thin layer chromatography, 8 thin-layer chromatography-fluorimetry, 9, 10 spectrofluorimetry, [11] [12] [13] capillary electrophoresis-fluorescence, 14 voltammetry, 15 and spectrophotometry [16] [17] [18] and Atomic absorption spectroscopy. 19 Some of these methods have suffered from various drawbacks including time consuming sample separation and treatment, expensive instruments and reagents, low sensitivity, inconvenient reagent pretreatment, and inability to assay real samples. Due to the sensitivity, selectivity and inexpensive instrumentation, the spectrofluorimetric (FL) method has been widely used in the quantification of pharmaceuticals.
In recent years, the use of lanthanides (especially Eu
3+
, Tb
) as fluorescence (FL) probes has become widespread because of their long luminescence life times, large Stokes shifts, and narrow emission bands. Because of these properties, the Eu 3+ complex has been used extensively as the FL probe in the assay of pharmaceuticals and biomolecules. ) was prepared by dissolving 0.017 g in a 50 mL volumetric flask using DI water and preserved at 4 o C. Tris-HCl buffer was prepared by dissolving an appropriate amount of tris (hydroxy methyl) aminomethane in 100 mL DI water and the pH was adjusted using 0.1 M HCl. Working solutions were prepared daily from the stock solution by appropriate dilution immediately before use.
Apparatus. All FL measurements were conducted using a spectrofluorimeter (F-4500, Hitachi, Japan) equipped with a 150 W xenon lamp. Emission lights of a sample solution were measured and transduced to electric signals by a photomultiplier tube (R 928, Hamamatsu, Japan). The high voltage for the photomultiplier tube was set to 950 V. A pH meter (Orion, 520A, USA) was used for pH adjustment. The absorption spectra of the system were measured on a UV-1800 spectrophotometer (Shimadzu, Japan).
Preparation of Samples. To analyze SPAR in serum and urine samples, these samples were spiked with appropriate amounts of SPAR stock solution. Each 1.0 mL serum sample was deproteinized by adding 5 mL of 20% trichloroacetic acid (CCl 3 COOH) in a centrifuge tube, followed by vortexing for 5 min and centrifuging for 10 min at 4000 rpm. A 0.1 mL aliquot of the supernatant of the serum sample was mixed with the standard solutions of SPAR and diluted appropriately within the linear range of determination. No further sample pretreatment was required for the urine sample except proper dilution in order to shift the SPAR concentrations within the working range.
Analytical Procedure. To measure the system's FL, certain amounts of Eu 3+ ion solution, buffer solution, SPAR, and SDBS were added to a 10 mL volumetric flask, diluted with DI water, mixed thoroughly, allowed to stand for about 20 min, and finally placed in a 1 cm quartz cell for measurement of the FL spectra. Both the excitation and emission slits for the FL measurement were set to 10 nm.
Results and Discussion
Fluorescence Spectral Characteristics. The fluorescence emission and excitation spectra of the SPAR-Eu
3+
-SDBS system were recorded at room temperature and are shown in Figure 1 . The experimental results showed that the Eu 3+ ion solution exhibited a very weak FL emission signal ( Fig. 1(a) , curve 1) because of weak absorption of the metal ion itself. After the addition of SPAR to the Eu 3+ solution, the characteristic emission signal of Eu 3+ ion appeared at 591 and 615 nm ( Fig. 1 3+ ion is predominantly associated with electric dipole, and their radiative transition probabilities are very sensitive to the nature of the ligand environment. Thus, the luminescence signal at 615 nm was intensified after addition of SPAR ( Fig.  1(a), curve 3) . SPAR can absorb light energy and transfer it to Eu 3+ through intramolecular energy transfer, and thereby form a binary mixture with Eu 3+ and emit characteristic FL signal of Eu 3+ . After the addition of SDBS to the SPAR-Eu 3+ system, SDBS improved the coordination microenvironment of Eu 3+ and SPAR and decreased the combination between the water molecules and the binary complex. Thus, the FL intensity of the SPAR-Eu 3+ binary complex was enhanced about 5 times as compared with the SPAR-Eu 3+ system in the presence of SDBS ( Fig. 1(a) , curve 4), which indicated that the existence of Eu 3+ and SDBS synergistically enhanced the FL intensity of SPAR.
As shown in the excitation spectra ( Fig. 1(b) ), the SPAREu
-SDBS system exhibited the maximum excitation intensity at about 372 nm, while the highest emission intensity was at 615 nm ( Fig. 1(a) ). Therefore, 372 and 615 nm was selected as the excitation and emission wavelengths for the whole experiment, respectively.
Effect of pH and Buffers. pH may have influenced the FL signal of the presented system. Thus, the effect of pH on the FL intensity was investigated in the range of 7-10. The maximum FL intensity was obtained at a pH of 8.8, which was therefore chosen as the optimum pH for this experiment. Buffer solutions may also influence the FL signal. Thus, the effect of the following buffers was examined: NH 4 Ac-HAc, borax-HCl, NH 4 Cl-NH 3 ·H 2 O, tris-HCl, KH 2 PO 4 -NaOH, and KH 2 PO 4 -Na 2 HPO 4 . The highest FL intensity was obtained using tris-HCl buffer (Fig. 2) . Therefore, 0.1 mol L −1 of trisHCl buffer was used to maximize the FL intensity.
Effect of Eu 3+ Ion Concentration. The effect of the Eu . The FL intensity was increased with increasing Eu 3+ ion concentration up to 4.7 × 10 −5 mol L −1 (Fig. 3) . Therefore, an Eu 3+ concentration of 4.7 × 10 −5 mol L −1 was selected for further study. Effect of SDBS Concentration. Surfactants are widely used to solubilize hydrophobic compounds and to increase the FL intensity of the weakly fluorescent compounds by improving the microenvironment of the fluorescence. The effect of the surfactants, cetyl trimethyl ammonium bromide (cationic), Triton X-100 (nonionic), Igepal (nonionic), sodium dodecyl sulfate (SDS, anionic), and SDBS (anionic), was investigated and the maximum signal was obtained using SDBS. The effect of SDBS on the FL intensity was determined and the FL intensity was maximized at an SDBS concentration of 5.8 × 10 −4 mol L −1 (Fig. 4) , which was thus chosen for the present study.
Effect of the Addition Order of the Reagents. The effect of the reagent addition order on the FL intensity was investigated. The results indicated that an addition order of Eu tris-HCl, SPAR, and SDBS maximized the FL intensity and so it was chosen as the optimum reagent addition order. Furthermore, the FL intensity of the system peaked at 20 min after all the reagents had been added and then remained stable for 2 h. Effect of Interfering Substances. The effect of potential interferents that may have influenced the analytical results by suppressing or enhancing the FL signal was systematically studied. Therefore, the effect of potential foreign substances was investigated by preparing a set of solutions, each containing 3.5 × 10 7 mol L −1 of SPAR and different concentrations of the chemical species to be tested. A foreign species is considered to interfere if it produces an error greater than 5% in the determination of SPAR. The results, summarized in Table 1 , indicated that the foreign substances did not significantly affect the FL intensity of the system for the determination of SPAR.
Possible Interaction Mechanism. In order to investigate the interaction between Eu 3+ , SPAR and SDBS, several absorption spectra of the system were recorded and are shown in Figures 5 and 6 . SPAR is a less polar and hydrophobic compound and its solubility were improved by SDBS. Thus, when the SPAR-Eu 3+ complex was dispersed and gathered around the micelles, the microenvironment of the complex was changed significantly, which may have decreased the non-radiative energy loss through the molecule collisions and improved the quantum efficiency of FL. 27 Moreover, the coordination number of Eu 3+ in its solution is usually 6-10, but this coordination number could not have been satisfied after SPAR-Eu 3+ complex formation. Thus, Eu 3+ in the SPAREu 3+ complex could interact with SDBS by ionic interaction, which facilitated energy transfer not only from SPAR to Eu
, but also from SDBS to Eu
, and thereby enhanced the FL of the system markedly. This explanation was proved by Figures 5 and 6 . The absorption of SDBS was enhanced when the Eu 3+ solution was mixed with SDBS ( Fig. 5 , curves 2 and 3), indicating that SDBS may have interacted with Eu
. As shown in Figure 6 , the absorption peak of SPAR (305 nm) was increased and the wavelength was red shifted from 305 to 369 nm (Fig. 6, curves 2 and 3) , thus revealing the formation of SPAR-Eu 3+ complex. However, the absorption of SPAR was enhanced significantly with the addition of both Eu 3+ and SDBS, which was in accordance with the FL increment of the FL excitation spectrum of the SPAR-Eu 3+ -SDBS system ( Fig. 1(b) ), and the maximum absorption wavelength showed a slight blue shift from about 369 to 365 nm (Fig. 6, curves 3 and 4) . Moreover, a multiple ionic associate that was formed in the SPAR-Eu
-SDBS system increased the effective absorption cross-section of the complex and thereby increased the molar absorbance index. Thus, the FL intensity of the system was significantly increased by the SDBS addition. In addition, the optimal SDBS concentration in the present study was approximated to the critical micelle concentration (0.63 mmol L −1
) of SDBS,
27 which indicated that the micelle formation strongly enhanced FL intensity of the system. Linear Range and Detection Limit. Under the optimal conditions described above, a calibration curve for the determination of SPAR was constructed by plotting the SPAR concentration versus FL intensity. The experimental results indicated that the enhanced FL intensities of the system SPAR. Thus, the presented method offers higher sensitivity (shown in Table 2 ) to determine SPAR with simple and cheap instrumentation. Determination of SPAR in Tablets. In order to demonstrate the applicability of the presented system, it was applied to the analysis of tablets containing SPAR. The results obtained by the proposed method, listed in Table 3 , indicated that the amount of SPAR obtained by the proposed method was in close agreement with the labeled contents. Recovery was performed by applying standard addition method. It was evaluated by determining the agreement between the measured concentration of the standard and the added known concentration of the sample. The test was performed by spiking the pre-analyzed powdered tablet sample at different concentrations with pure SPAR. Each test was repeated five times and the recoveries were in the range of 95-102.75% for SPAR.
Determination of SPAR in Spiked Serum and Urine Samples. The proposed method was used to determine the SPAR contents in the serum and urine samples. In order to adjust the sample SPAR concentration within the linear range of determination, after deproteinization and centrifugation of serum and urine samples, the supernatant was used to investigate the recovery by standard addition method where known amounts of SPAR were added. The results of the spiked serum and urine samples are shown in Table 4 . Recoveries of SPAR contents in serum and urine samples were 97.83-101.57% and 98.5-104.5%, respectively. Therefore, the proposed method can be applied to determine SPAR in serum and urine samples with good accuracy. , the coordination ratio of Eu
3+
: SPAR was determined to be 1:2 by Job's method of continuous variation of equimolar solution. The SPAR molecule contains two types of coordinating atoms: oxygen and nitrogen. The oxygen atom has a tendency to form a stable complex with a lanthanide element, due to its strong ability of coordination with the lanthanide compounds. However, the stability of the complex formed by a nitrogen atom and a lanthanide element is relatively poor. Usually, oxygen atoms in an organic ligand coordinate with the lanthanide compounds in one of two ways: the negatively charged oxygen atom forms a stable ionic bond with the lanthanide ion or the electro-neutral oxygen atom forms a coordinate bond with the lanthanide ion.
28 Based on the above discussion, a structure was proposed for the binary complex of Eu 3+ and SPAR and is shown in Figure 7 .
Conclusion
A sensitive and cost effective FL method was proposed for determining SPAR based on the interaction of Eu 3+ and SPAR in the presence of SDBS. The proposed method offers higher sensitivity, selectivity and accuracy with a lower limit of detection (4.15 × 10 −10 mol L ). The presented method was successfully applied to the determination of SPAR in formulated pharmaceutical tablets, and serum and urine samples. 
